Abstract:Abstract Background Omega-3 (ω-3) fatty acid (FA)-containing parenteral nutrition (PN) is associated with significant improvements in patient outcomes compared with standard PN regimens without ω-3 FA lipid emulsions. Here, we evaluate the impact of ω-3 FA-containing PN versus standard PN on clinical outcomes and costs in adult intensive care unit (ICU) patients using a meta-analysis and subsequent cost-effectiveness analysis from the perspective of a hospital operating in five European countries (France, Germany, Italy, Spain, UK) and the US. Methods We present a pharmacoeconomic simulation based on a systematic literature review with meta-analysis. Clinical outcomes and costs comparing ω-3 FA-containing PN with standard PN were evaluated in adult ICU patients eligible to receive PN covering at least 70% of their total energy requirements and in the subgroup of critically ill ICU patients (mean ICU stay > 48 h). The meta-analysis with the co-primary outcomes of infection rate and mortality rate was based on randomized controlled trial data retrieved via a systematic literature review; resulting efficacy data were subsequently employed in country-specific cost-effectiveness analyses. Results In adult ICU patients, ω-3 FA-containing PN versus standard PN was associated with significant reductions in the relative risk (RR) of infection (RR 0.62; 95% CI 0.45, 0.86; p = 0.004), hospital length of stay (HLOS) (− 3.05 days; 95% CI − 5.03, − 1.07; p = 0.003) and ICU length of stay (LOS) (− 1.89 days; 95% CI − 3.33, − 0.45; p = 0.01). In critically ill ICU patients, ω-3 FA-containing PN was associated with similar reductions in infection rates (RR 0.65; 95% CI 0.46, 0.94; p = 0.02), HLOS (− 3.98 days; 95% CI − 6.90, − 1.06; p = 0.008) and ICU LOS (− 2.14 days; 95% CI − 3.89, − 0.40; p = 0.02). Overall hospital episode costs were reduced in all six countries using ω-3 FA-containing PN compared to standard PN, ranging from €-3156 ± 1404 in Spain to €-9586 ± 4157 in the US. Conclusion These analyses demonstrate that ω-3 FA-containing PN is associated with statistically and clinically significant improvement in patient outcomes. Its use is also predicted to yield cost savings compared to standard PN, rendering ω-3 FA-containing PN an attractive cost-saving alternative across different health care systems. Study registration PROSPERO CRD42019129311.

Cost and Effectiveness of Omega-3 Fatty Acid Supplementation in Chinese ICU Patients Receiving Parenteral Nutrition

Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis

Cost analysis of Omega-3 supplementation in critically ill patients with sepsis

Effectiveness of Pharmaceutical Care in an Intensive Care Unit from China A Pre- and Post-Intervention Study

Clinical Effect of Multi-Oil Fat Emulsion for Parenteral Nutrition Support in Extremely Low Birth Weight Infants

[Use of Fish Oil Lipid Emulsion in Patients Undergoing Major Surgery and Those with Systemic Inflammatory Response Syndrome: a Cost-Effectiveness Analysis].

Pharmacoeconomics of parenteral nutrition in surgical and critically ill patients receiving structured triglycerides in China.

The Impact of Fish Oil (Ω-3 Fatty Acids) Intervention on Infectious Complications and Cost-Effectiveness for Postoperative Patients: Systematic Review (2010-2016)

The role of lipid emulsions containing omega-3 fatty acids for medical and surgical critical care patients

Impact of Omega-3 Fatty Acid Supplementation in Parenteral Nutrition on Inflammatory Markers and Clinical Outcomes in Critically Ill COVID-19 Patients: A Randomized Controlled Trial

A Quality Improvement Program with Nutrition Therapy: Restriction of Lipid Emulsions in Cardiac Surgical Patients.

Prevention effects of omega-3 fish oil emulsions on parenteral nutrition-associated liver disease

Impact of Short-Term Omega-3 Fatty Acids Supplementation on Clinical Outcomes in Postoperative Patients with Parenteral Nutrition Support: a Meta-analysis of Randomized Controlled Trials

ω-3 fatty acids - Supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study

Oral nutritional supplements improve clinical outcomes and are cost effective for hospitalized patients in China

The Efficacy of Parenteral Fish Oil in Critical Illness Patients with Sepsis: a Prospective, Non-Randomized, Observational Study

Effect of intravenous omega-3 fatty acids on outcome of patients with sepsis: a systematic review and meta-analysis

The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial

Is Omega-3 Fatty Acids Enriched Nutrition Support Safe for Critical Ill Patients? A Systematic Review and Meta-Analysis

Is There an Advantage in Enriching Parenteral Lipid Emulsions Containing Fatty Acids From Fish Oil With Medium-Chain Triglycerides? A Study on Body Pool Concentrations of ω-3 Fatty Acids in Lewis Rats

Effects of Ω‐3 Fish Oil Lipid Emulsion Combined with Parenteral Nutrition on Patients Undergoing Liver Transplantation